These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1329853)

  • 1. Intranasal application of atrial natriuretic peptide and 1-deamino-d-arginine vasopressin in healthy volunteers. Hemodynamic, hormonal, and renal excretory effects.
    Predel HG; Kuklinski P; Kramer HJ
    Am J Hypertens; 1992 Sep; 5(9):657-60. PubMed ID: 1329853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses.
    Predel HG; Schulte-Vels O; Glänzer K; Meyer-Lehnert H; Kramer HJ
    Am J Hypertens; 1991 Nov; 4(11):871-9. PubMed ID: 1665067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
    Mori K
    Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H; Pedersen EB
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.
    Holmes SJ; Espiner EA; Richards AM; Yandle TG; Frampton C
    J Clin Endocrinol Metab; 1993 Jan; 76(1):91-6. PubMed ID: 8380606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.
    Beland B; Tuchelt H; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1994 Jul; 79(1):183-8. PubMed ID: 8027224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans.
    Bruun NE; Skøtt P; Giese J
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R217-24. PubMed ID: 1847023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
    Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of centrally administered atrial natriuretic peptide on renal functions.
    Shoji M; Kimura T; Matsui K; Ota K; Iitake K; Inoue M; Yasujima M; Abe K; Yoshinaga K
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):433-40. PubMed ID: 2957880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
    Bidiville J; Waeber G; Porchet M; Nussberger J; Biollaz J; Gomez H; Callahan L; Waeber B; Brunner HR
    Fundam Clin Pharmacol; 1988; 2(5):413-29. PubMed ID: 2976727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide in patients with diabetes mellitus type I. Effects on systemic and renal hemodynamics and renal excretory function.
    Predel HG; Schulte-Vels O; Sorger M; Glänzer K; Geller C; Kramer HJ
    Am J Hypertens; 1990 Sep; 3(9):674-81. PubMed ID: 2145873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
    Rocco S; Opocher G; Carpenè G; Mantero F
    Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal administration of alpha-human natriuretic peptide produces a prolonged diuresis in healthy man.
    Shionoiri H; Kaneko Y
    Life Sci; 1986 Mar; 38(9):773-8. PubMed ID: 2936943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension].
    Mori K; Shigetomi S; Kohno H; Tosaki H; Kato K; Tanaka K; Haga H; Kin S; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):83-93. PubMed ID: 2158911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.